Krystal Biotech (KRYS) Profit After Tax (2016 - 2026)
Krystal Biotech (KRYS) posted quarterly Profit After Tax of $54.8 million for Q2 2026, up 40.07% year-over-year from $39.1 million in Q2 2025, and down 2.08% on a QoQ basis from $55.9 million in Q1 2026.
Krystal Biotech (KRYS) Profit After Tax (2016 - 2026) Analysis & Trends
Krystal Biotech has reported Profit After Tax for 11 years, with the latest figure at $54.8 million in Q2 2026.
- Profit After Tax for Q2 2026 came in at $54.8 million, up 40.07% year-over-year; the trailing twelve-month figure through Jun 2026 was $241.5 million (up 62.34% YoY), and the FY2025 annual result was $206.2 million, up 131.22% from the prior year.
- Profit After Tax fell to $54.8 million in Q2 2026, from $55.9 million in the prior quarter.
- Over five years, Profit After Tax peaked at $80.7 million in Q3 2023 and troughed at -$50.0 million in Q1 2022.
- A 5-year average of $15.5 million and a median of $22.4 million in 2024 frame the typical range for Profit After Tax.
- The widest annual swing landed in 2022, when Profit After Tax sank 215.99%; it then soared 3734.01% in 2025.
- A 5-year view of Profit After Tax shows it stood at -$31.3 million in 2022, then jumped by 131.02% to $9.7 million in 2023, then soared by 359.28% to $44.6 million in 2024, then climbed by 15.31% to $51.4 million in 2025, then rose by 6.48% to $54.8 million in 2026.
- Per Business Quant data, the three most recent Profit After Tax figures were $54.8 million in Q2 2026, $55.9 million in Q1 2026, and $51.4 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.10 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.30 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 472.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -644.37 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 237.01 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -3,087.27 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 81.49 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 164.49 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -16.62 Mn |
| 10 | Krystal Biotech | 9.83 Bn | 8.99 Bn | 112.79 Mn | 54.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 54.77 Mn |
| Mar 31, 2026 | 55.93 Mn |
| Dec 31, 2025 | 51.40 Mn |
| Sep 30, 2025 | 79.37 Mn |
| Jun 30, 2025 | 38.33 Mn |
| Mar 31, 2025 | 36.31 Mn |
| Dec 31, 2024 | 45.48 Mn |
| Sep 30, 2024 | 29.33 Mn |
| Jun 30, 2024 | 15.57 Mn |
| Mar 31, 2024 | 932,000.00 |
| Dec 31, 2023 | 8.35 Mn |
| Sep 30, 2023 | 80.60 Mn |
| Jun 30, 2023 | -33.21 Mn |
| Mar 31, 2023 | -45.30 Mn |
| Dec 31, 2022 | -32.05 Mn |
| Sep 30, 2022 | -29.78 Mn |
| Jun 30, 2022 | -28.11 Mn |
| Mar 31, 2022 | -49.97 Mn |
| Dec 31, 2021 | -21.96 Mn |
| Sep 30, 2021 | -15.59 Mn |